243 related articles for article (PubMed ID: 36013323)
1. The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges.
Costa S; Ragusa MA; Lo Buglio G; Scilabra SD; Nicosia A
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013323
[TBL] [Abstract][Full Text] [Related]
2. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of a Protein Structure in the Dynamic Evolution of TIMPs over 600 Million Years.
Nicosia A; Maggio T; Costa S; Salamone M; Tagliavia M; Mazzola S; Gianguzza F; Cuttitta A
Genome Biol Evol; 2016 Apr; 8(4):1056-71. PubMed ID: 26957029
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation.
Hirt-Minkowski P; Marti HP; Hönger G; Grandgirard D; Leib SL; Amico P; Schaub S
Transpl Immunol; 2014 Jan; 30(1):1-6. PubMed ID: 24291496
[TBL] [Abstract][Full Text] [Related]
5. Phylotranscriptomic analysis uncovers a wealth of tissue inhibitor of metalloproteinases variants in echinoderms.
Clouse RM; Linchangco GV; Kerr AM; Reid RW; Janies DA
R Soc Open Sci; 2015 Dec; 2(12):150377. PubMed ID: 27017967
[TBL] [Abstract][Full Text] [Related]
6. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
Wang L; Almqvist KF; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation.
Henriet P; Blavier L; Declerck YA
APMIS; 1999 Jan; 107(1):111-9. PubMed ID: 10190287
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.
Peeney D; Liu Y; Lazaroff C; Gurung S; Stetler-Stevenson WG
Carcinogenesis; 2022 Jun; 43(5):405-418. PubMed ID: 35436325
[TBL] [Abstract][Full Text] [Related]
9. TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases.
Almuntashiri S; Alhumaid A; Zhu Y; Han Y; Dutta S; Khilji O; Zhang D; Wang X
Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):67-76. PubMed ID: 38343891
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of the Extracellular Matrix in Rat Anterior Pituitary Gland: Identification of Cells Expressing Tissue Inhibitors of Metalloproteinases.
Azuma M; Tofrizal A; Maliza R; Batchuluun K; Ramadhani D; Syaidah R; Tsukada T; Fujiwara K; Kikuchi M; Horiguchi K; Yashiro T
Acta Histochem Cytochem; 2015 Dec; 48(6):185-92. PubMed ID: 26855451
[TBL] [Abstract][Full Text] [Related]
11. Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1.
Lee MH; Atkinson S; Murphy G
J Biol Chem; 2007 Mar; 282(9):6887-98. PubMed ID: 17202148
[TBL] [Abstract][Full Text] [Related]
12. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
Brew K; Nagase H
Biochim Biophys Acta; 2010 Jan; 1803(1):55-71. PubMed ID: 20080133
[TBL] [Abstract][Full Text] [Related]
13. TIMPs: versatile extracellular regulators in cancer.
Jackson HW; Defamie V; Waterhouse P; Khokha R
Nat Rev Cancer; 2017 Jan; 17(1):38-53. PubMed ID: 27932800
[TBL] [Abstract][Full Text] [Related]
14. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Nagase H; Brew K
Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): new aspects in hematopoiesis.
Murate T; Hayakawa T
Platelets; 1999; 10(1):5-16. PubMed ID: 16801065
[TBL] [Abstract][Full Text] [Related]
16. Tracing the evolution of tissue inhibitor of metalloproteinases in Metazoa with the
Ma CY; Chen Y; Zhan X; Dong YW
iScience; 2024 Jan; 27(1):108579. PubMed ID: 38161420
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase A activity directly modulates melanoma cell adhesion and spreading.
Ray JM; Stetler-Stevenson WG
EMBO J; 1995 Mar; 14(5):908-17. PubMed ID: 7534227
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitors of metalloproteases: regulation and biological activities.
Fassina G; Ferrari N; Brigati C; Benelli R; Santi L; Noonan DM; Albini A
Clin Exp Metastasis; 2000; 18(2):111-20. PubMed ID: 11235986
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
Tofrizal A; Fujiwara K; Azuma M; Kikuchi M; Jindatip D; Yashiro T; Yamada S
Med Mol Morphol; 2017 Sep; 50(3):145-154. PubMed ID: 28353090
[TBL] [Abstract][Full Text] [Related]
20. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth.
Edwards DR; Beaudry PP; Laing TD; Kowal V; Leco KJ; Leco PA; Lim MS
Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S9-15. PubMed ID: 8680484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
